Leading global ophthalmic CRO Ora announces appointment of pharmaceutical industry veteran Bill Sharbaugh as Chairman of Board of Directors.

Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity By George Budwell – Jul 4, 2025 at 4:30AM ...

-- AstraZeneca is in talks with Summit Therapeutics for a deal in which it could pay as much as $15 billion over time to license a lung-cancer drug, Bloomberg reported Thursday, citing people ...

Axsome Therapeutics AXSM has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on June 30, 2025 that were previo ...

AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 billion, expanding its product pipeline with experimental treatments ...

Cambridge biotech firm Sage Therapeutics is laying off most of its employees after announcing its planned acquisition earlier this month. Sage will cut 338 jobs effective Aug. 22, according to ...

Sage Therapeutics is laying off most of its employees after announcing its planned acquisition earlier this month.